Johnson & Johnson (JNJ) Financial Analysis & Valuation | Quarter Chart

Johnson & Johnson (JNJ)

JNJ
Price: $223.4
Fair Value: 🔒
🔒score
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the... more
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and se... more
Description Shares
Market Cap$537.77BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryUSCEOJoaquin Duato
IPO Date1943-01-02CAGR0.07%
Employees138,100Websitewww.jnj.com
Div. Yield2.33%Payout Ratio0.6%
Buy Back Yield1.11%Total Yield3.44%
JNJ chart loading...
Fundamentals Technicals
Enterprise Value$588.72BP/E Ratio25.86
Forward P/E17.67PEG Ratio-0.49
P/S Ratio5.58P/B Ratio6.73
P/CF Ratio23.89P/FCF Ratio30.22
EPS$8.63EPS Growth 1Y-3.78%
EPS Growth 3Y80.96%EPS Growth 5Y52.83%
Revenue Growth 1Y7.87%Gross Margin0.69%
Operating Margin0.27%Profit Margin0.22%
ROE0.26%ROA0.1%
ROCE0.18%Current Ratio1.03
Quick Ratio0.77Cash Ratio0.38
Debt/Equity0.22Interest Coverage31.97
Altman Z Score4.82Piotroski Score7

View Johnson & Johnson financial charts →